EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Taxation/Internal Revenue Code TAX

Implementation of tax provisions of the ACA, including the insurer tax. Tax reform policies.

Contacted: Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Congressional Budget Office (CBO); SENATE; Labor, Dept of (DOL); Food & Drug Administration (FDA); Internal Revenue Service (IRS); White House Office; Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Health Resources & Services Administration (HRSA)

Defense DEF

Pharmacy issues related to the annual defense authorization and implementation of the 2017 NDAA.

Contacted: Office of Personnel Management (OPM); Federal Trade Commission (FTC); SENATE; Executive Office of the President (EOP); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Congressional Budget Office (CBO); Labor, Dept of (DOL)

Health Issues HCR

Regulatory policies related to the health reform law, including drug benefits and disclosure. Implementation of HITECH. Prescription drug affordability issues. Reforms to Medicaid and Exchange markets.

Contacted: Office of Personnel Management (OPM); Labor, Dept of (DOL); Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); White House Office; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Internal Revenue Service (IRS); SENATE; Medicare Payment Advisory Commission (MedPAC)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap, direct negotiation of prescription drug prices. Implementation of opioid abuse "lock in" provisions from CARA. Medicare Part B reforms. S. 637; HR 1920; HR 1939.

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Labor, Dept of (DOL); HOUSE OF REPRESENTATIVES; SENATE; White House Office; Congressional Budget Office (CBO); Internal Revenue Service (IRS); Federal Trade Commission (FTC); Office of Personnel Management (OPM)

Bills named: S. 637 (115th), H.R. 1939 (115th), H.R. 1920 (115th)

Pharmacy PHA

Design and coverage of pharmacy benefits in Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, EPCS, electronic prior authorization, PBM disclosure, MLR, and specialty pharmacy tiering. Implementation of biosimilars pathway from BPCIA. Policies placing restrictions on pharmacy benefit design. Issues relating to prescription drug affordability. REMS reform. Prescription drug user fee reauthorization. HR 1854; S. 788; HR 2025.

Contacted: Congressional Budget Office (CBO); SENATE; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Executive Office of the President (EOP); White House Office; Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Office of Personnel Management (OPM)

Bills named: S. 788 (115th), H.R. 2025 (115th), H.R. 1854 (115th)